Log In | Register FREE | Schedule a DEMO | Solution Enquiry | Subscribe
Start Your FREE TRIAL Start Your FREE TRIAL
X

Nath Bio-Genes (India) Ltd Stock Analysis

Small Cap
Evaluated by 228 users | BSE: 537291 | NSE: NATHBIOGEN |
Agriculture
10YEAR X-RAY

10 Year X-Ray

Standalone basis Standalone basis P Consolidated basis

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 18.69%19.65%21.4%30%24.41%12.01%8.27%8.35%7.86%9.2%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 100124138172185162170192231280
Y-o-Y Gr. Rt.-23.4%11.1%25%7.7%-12.5%4.8%12.8%20.5%21.2%
Adjusted EPS (Rs.) 12.385.767.2915.1615.828.8410.1415.4720.1126.44
Y-o-Y Gr. Rt.--53.5%26.6%108%4.4%-44.1%14.7%52.6%30%31.5%
Book Value per Share (Rs.) 41.928.5735.9151.166.9475.8189.52246.91267.09293.42
Adjusted Net Profit 89.211.724.325.314.116.229.438.250.2
Net Op. Cash Flow (Rs. Cr.) 000.7155.9-13.63.3-47-22.99.5
Debt to Cash Flow from Ops 0028.221.533.75-4.3222.08-0.69-2.547.4
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Nath Bio-Genes (India) Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 12.1%8.6%18.1%21.2%
Adjusted EPS 8.8%10.8%37.6%31.5%
Book Value per Share 24.134.415.79.9
Share Price - 31.3% -13.9% -8.2%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 21.822.3922.634.8526.8112.387.647.617.839.43
Operating Profit Margin (%) 13.3111.8614.4519.5518.7515.217.0821.1318.7819.61
Net Profit Margin (%) 7.937.438.4714.113.668.729.5515.3416.5517.95
Debt to Equity 0.490.250.320.280.210.480.240.070.110.13
Working Capital Days 0253279298365490500520553555
Cash Conversion Cycle 0170167150169262263264280271
shareholding patterns

Shareholding Pattern

Entity Percentage Holding
Promoters 41.79%
Institutions 11.04%
Non-Institutions 47.17%
shareholding patterns

Promoter's Holding & Share Pledging

Pledged *32.3331.1115.8919.0019.7821.0645.7744.6336.3140.09
* Pledged shares as % of Promoter's holding (%)
shareholding patterns

FAQs

1. Is Nath Bio-Genes (India) Ltd a good quality company?
Data is not available for this company.
2. Is current market price of Nath Bio-Genes (India) Ltd a good price to buy it?

The 5-year analysis of Nath Bio-Genes (India) Ltd's performance infers:

Nath Bio-Genes (India) Ltd earnings have grown by 10.8%, whereas share price has appreciated 31.3% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

3. What is Nath Bio-Genes (India) Ltd share price return in the past 10 years ?

Data is not available for this company

shareholding patterns

About Company

No data to display
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback